CyFluATG in Lower Risk MDS
Conditions: Myelodysplastic Syndromes Interventions: Drug: cyclophosphamide, fludarabine, and antithymocyte globulin Sponsors: Asan Medical Center Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Myelodysplastic Syndrome | Research